What Is Central Obesity and How Do You Manage It?

Central obesity is the accumulation of excess fat in and around the abdomen, particularly the deep visceral fat that surrounds internal organs. Unlike overall obesity measured by body mass index alone, central obesity zeroes in on where fat is stored, and that distinction matters because visceral fat is far more metabolically active and damaging than fat stored under the skin on hips or thighs. A waist circumference above roughly 102 cm (40 inches) for men or 88 cm (35 inches) for women is the commonly used threshold, though the right cutoff depends on your ethnic background. Managing central obesity involves a mix of aerobic exercise, dietary changes, adequate sleep, and, in some cases, newer medications that specifically target visceral fat stores.

Why Belly Fat Is Not Just Regular Fat

Your body stores fat in two fundamentally different compartments. Subcutaneous fat sits just below the skin, the kind you can pinch. Visceral fat packs in deeper, wrapping around your liver, intestines, kidneys, and pancreas. These two fat types behave almost like different organs. Visceral fat cells are more metabolically active, quicker to release fatty acids into the bloodstream, and more resistant to insulin’s signals than subcutaneous fat cells.¹ They also differ in how they grow, how they handle inflammation, and how they respond to hormonal signals.²

The trouble doesn’t stop with visceral fat itself. As visceral fat expands, it drives fat to accumulate in organs that aren’t designed to store it. MRI studies show that the degree of central obesity correlates with fat infiltration into the pancreas, liver, and skeletal muscle, and that visceral fat is the main predictor of this so-called ectopic fat buildup, independent of overall body weight.^{3 4} This ectopic fat gums up organ function and pushes metabolic health further off track. Obese men tend to accumulate more of this liver and pancreatic fat than obese women at the same BMI, which partly explains why men face higher cardiovascular risk at the same weight.

How Central Obesity Is Measured

The simplest tool is a tape measure. Waist circumference is cheap, fast, and surprisingly good at estimating visceral fat. A study comparing several measurement methods found that waist circumference and waist-to-height ratio both correlated strongly with visceral fat levels, whereas bioelectrical impedance analysis, the technology built into many consumer body-composition scales, classified far fewer people as having abdominal obesity.⁵ In other words, your bathroom scale’s “visceral fat” reading may underestimate the problem.

Where you place the tape also makes a difference. Most guidelines say to measure at the midpoint between the lowest rib and the top of the hip bone, but research on middle-aged adults found that measuring at the rib margin itself produced stronger associations with metabolic risk factors like insulin resistance, blood pressure, and type 2 diabetes. That rib-level measurement improved the ability to identify diabetes risk by several percentage points compared with the standard midpoint approach.⁶ In practice, this detail matters less for home screening and more for clinical settings, but it is worth knowing that a slightly higher tape position may catch risk that the standard spot misses.

Waist-to-height ratio is gaining traction as a simple alternative. A ratio above 0.5 flags elevated risk regardless of your height, which makes it easy to remember: your waist should measure less than half your height.⁷

Measurement Thresholds Vary by Ethnicity

The commonly cited waist circumference thresholds were developed primarily from studies of European-descent populations, and they don’t fit everyone equally. Research suggests that Asian populations likely need lower cutoffs because they tend to develop metabolic complications at smaller waist sizes.⁸ For African American women, the optimal waist circumference threshold for detecting metabolic risk may be about 5 cm higher than the standard threshold used for white women, roughly 97 cm versus 92 cm.⁹ In men, ethnic differences in the optimal thresholds are smaller and less consistent.

A separate analysis across white, Black, and Mexican American adults found that simplified waist circumference cutoffs corresponding to overweight and obese BMI levels were about 89 cm and 101 cm for men and 83 cm and 94 cm for women, with white men having cutoffs roughly 5-6 cm higher than Black men.¹⁰ The practical takeaway is that applying one-size-fits-all thresholds can miss risk in some groups and overcount it in others. If you’re using waist circumference to track your own health, your doctor should ideally be referencing population-appropriate cutoffs.

The Cardiovascular Toll

Central obesity is one of the strongest predictors of heart disease, and it outperforms BMI as a danger signal. A large meta-analysis pooling data from over 80,000 participants across nine cohort studies found that waist circumference and waist-to-hip ratio were both independently linked to cardiovascular death, while BMI was not, after adjusting for other risk factors. People in the highest fifth of waist-to-hip ratio had a 66% greater risk of dying from cardiovascular disease compared with those in the lowest fifth.¹¹

A population-based cohort study of middle-aged and older adults put numbers on the combined effect of BMI and central obesity. Compared to people with normal weight and normal waist circumference, those with central obesity but a normal BMI had about a 28% higher risk of cardiovascular disease. People who were both generally overweight and centrally obese had roughly a 49% higher risk.¹² The central obesity alone group is especially striking because these are people whose BMI would not have raised any flags.

Normal Weight Central Obesity Is a Hidden Risk

This is one of the most underappreciated patterns in metabolic health. You can have a perfectly normal BMI and still carry a dangerous amount of visceral fat. People with normal-weight central obesity, sometimes called “thin on the outside, fat on the inside,” face a mortality risk from cardiometabolic disease that may equal or exceed the risk in people who are both centrally obese and overweight by BMI.⁷ A national database analysis found that even after adjusting for other conditions, normal-weight people with central obesity had a greater risk of heart failure and atrial fibrillation compared to normal-weight people without central obesity.¹³

The danger here is invisibility. These individuals rarely get flagged in routine screenings because their BMI looks fine. They’re less likely to receive dietary counseling or be prescribed preventive medication. If your waist-to-height ratio exceeds 0.5 despite a normal weight on the scale, that is worth a conversation with your doctor.

How Inflammation Connects Belly Fat to Metabolic Disease

Visceral fat doesn’t just sit there storing energy. As it expands, fat cells begin to malfunction. They secrete inflammatory signaling molecules and attract immune cells that normally fight infections, creating a state of chronic low-grade inflammation inside the abdominal cavity.¹⁴ This inflammation spills over into the bloodstream and affects distant organs, contributing to insulin resistance, fatty liver buildup, and blood vessel damage.¹⁵

Tumor necrosis factor-alpha (TNF-alpha) is one of the key inflammatory molecules produced by enlarged visceral fat tissue. It interferes with how fat cells store and release lipids and how they respond to insulin, creating a self-reinforcing cycle where inflammation worsens fat dysfunction and fat dysfunction worsens inflammation.¹⁶ Breaking this cycle is a big part of why reducing visceral fat has such outsized health benefits compared to simply losing weight in general.

What Drives Fat Toward the Belly

Several forces push the body to preferentially store fat in the abdomen rather than elsewhere. Understanding them helps explain why central obesity is not simply a matter of eating too much.

Cortisol and stress are consistently implicated. People with abdominal obesity tend to have elevated cortisol levels, and the stress hormone system is tightly intertwined with how the body regulates energy storage.¹⁷ This isn’t just an adult problem. Research in children found that school-related stress was linked to greater visceral fat accumulation, but only in girls with a high cortisol awakening response, suggesting that it’s not stress alone but how your body reacts to stress that determines whether it packs fat centrally.¹⁸ In women under chronic stress, eating highly palatable food (the comfort-food effect) was associated with more abdominal fat and higher markers of oxidative stress and insulin resistance, and this link was stronger in women with elevated levels of neuropeptide Y, a stress-related appetite signal.¹⁹

Menopause is another major driver. As estrogen levels decline, fat distribution shifts from the hips and thighs toward the abdomen. Studies tracking women across the menopausal transition show significant increases in both total body fat and visceral fat area as women move from premenopausal to postmenopausal status. The shift is most pronounced in women who start at a normal weight.²⁰ Women who are already overweight see a smaller relative change, likely because fat distribution was already trending central before menopause.

Sleep plays a surprisingly large role. A study using national health survey data found that shorter sleep was associated with greater visceral fat mass after adjusting for overall body fat and other lifestyle factors, with the benefit of additional sleep appearing to plateau around eight hours per night.²¹ Longitudinal research confirms this: over five years, adults under 40 who slept five hours or less accumulated substantially more visceral fat than those sleeping six to seven hours. Interestingly, sleeping eight or more hours was also linked to greater fat gain, suggesting a U-shaped relationship where both too little and too much sleep promote belly fat.²² One encouraging finding from a six-year study was that people who shifted from sleeping six hours or less to seven or eight hours gained less visceral fat than those who stayed short sleepers.²³

Diet composition matters beyond total calories. In adolescents, higher fructose consumption was specifically associated with more visceral fat after adjusting for total energy intake, body composition, and physical activity, and the metabolic risk markers tied to fructose appeared to be mediated through visceral fat rather than subcutaneous fat.²⁴ Animal research supports a causal link, showing that fructose-rich diets trigger inflammation specifically in visceral fat tissue.²⁵

Environmental Chemicals and Visceral Fat

An emerging area of research involves endocrine-disrupting chemicals, synthetic compounds found in plastics, pesticides, food packaging, and personal care products. These so-called “obesogens” interfere with hormonal signaling and have been causally linked to fat gain in animal models and associated with obesity in human population studies.²⁶ Because they disrupt the hormonal pathways that regulate fat storage, some researchers argue that chemical exposures could be a meaningful and overlooked contributor to the rise in central obesity, particularly because hormonal disruption can influence where fat is deposited, not just how much.²⁷ The evidence is still building, and no one is suggesting that chemical exposure is a bigger factor than diet or exercise. But it’s worth being aware that your personal care products and food containers could be nudging your metabolic system in an unfavorable direction.

Exercise for Visceral Fat Loss

Not all exercise is created equal when it comes to visceral fat. A meta-analysis comparing aerobic exercise to resistance training found that aerobic exercise significantly reduced visceral fat compared to no exercise, while resistance training alone did not produce a meaningful reduction in visceral fat stores.²⁸ A head-to-head trial in overweight adults confirmed this: aerobic training led to significant reductions in visceral fat, liver fat, and insulin resistance, while resistance training reduced subcutaneous abdominal fat but did not significantly improve the others.²⁹

This doesn’t mean resistance training is useless. Building muscle improves insulin sensitivity, resting metabolic rate, and functional capacity. But if your primary goal is shrinking visceral fat, aerobic exercise is the more efficient tool. Brisk walking, cycling, swimming, or jogging for a moderate amount of time appears sufficient; the meta-analysis noted that even amounts below the standard 150-minute-per-week recommendation produced meaningful reductions in visceral fat.

Dietary Approaches That Target Visceral Fat

Calorie restriction works, but the composition of the diet seems to matter for visceral fat specifically. A trial testing a high-polyphenol Mediterranean diet found that it reduced visceral fat by about 14%, significantly more than both a standard Mediterranean diet (about 6% reduction) and basic healthy dietary guidelines (about 4% reduction). The extra visceral fat loss persisted even after adjusting for differences in waist circumference change and overall weight loss, suggesting something about the polyphenol-rich foods, things like green tea and a specific aquatic plant called Mankai, was having an independent effect on deep belly fat.³⁰

A separate trial found that a standard Mediterranean diet, even without added polyphenol sources, reduced estimated visceral fat mass compared to a control diet. Adding calorie restriction on top of the Mediterranean diet produced greater overall weight loss but a similar degree of visceral fat reduction.³¹ The pattern across these trials points toward plant-rich, fiber-heavy eating patterns as effective for visceral fat reduction, potentially beyond what calorie cutting alone achieves.

Medications That Reduce Visceral Fat

The new generation of GLP-1 receptor agonist drugs, the class that includes semaglutide and liraglutide, has changed the pharmacological landscape for central obesity. A systematic review and meta-analysis found that GLP-1 receptor agonists significantly reduced both visceral fat and liver fat compared to control treatments, in adults with and without diabetes.³² Studies of semaglutide specifically show that it preferentially reduces fat mass, particularly visceral fat, while the proportion of lean body mass relative to total body weight actually increases.³³ In patients with poorly controlled type 2 diabetes, adding semaglutide to metformin significantly lowered the visceral adiposity index, with the largest improvements seen in those with obesity.³⁴

Bariatric surgery remains the most powerful intervention for severe central obesity. Procedures like gastric bypass and sleeve gastrectomy reduce visceral fat volumes substantially, and the degree of reduction in specific fat depots around the kidneys and aorta has been linked to metabolic improvements after surgery.³⁵ Surgery is typically reserved for people with severe obesity or those who have not responded to other approaches, but its ability to rapidly reduce visceral and ectopic fat stores is unmatched.

An Evolutionary Angle on Visceral Fat

One intriguing hypothesis proposes that visceral fat may not have been purely harmful for most of human history. Because the visceral fat compartment is closely tied to the immune system of the gut, one researcher has proposed that evolution favored greater investment in visceral fat in populations facing chronic malnutrition and intestinal infections, since visceral fat plays a role in fueling immune responses against abdominal pathogens.³⁶ In that light, the tendency to store fat viscerally may have been protective in certain environments. The problem is that in a modern context of abundant calories and little infectious disease, the same tendency becomes a metabolic liability. This is still a hypothesis rather than settled science, but it offers a more nuanced view of why the body stores fat where it does, and why fighting central obesity can feel like pushing against a deeply wired biological default.